Exploring biomarkers for noise-induced hearing loss through mitochondrial DNA methylation analysis

This study demonstrates a reduction in mitochondrial DNA methylation, particularly in the ATP6 and CYB genes, among individuals with NIHL. These findings suggest that mitochondrial DNA methylation, especially in the CYB gene, could serve as a potential biomarker for NIHL. However, given the complex interplay of various factors, including genetic, environmental, and lifestyle influences, further research is needed to fully understand the role of mitochondrial DNA methylation and oxidative stress in NIHL. Future studies should focus on identifying additional biomarkers and elucidating their mechanistic relationships, which could lead to more accurate diagnostic tools and therapeutic strategies.